These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2277972)

  • 41. A controlled study of ranitidine for the prevention of recurrent hemorrhage from duodenal ulcer.
    Jensen DM; Cheng S; Kovacs TO; Randall G; Jensen ME; Reedy T; Frankl H; Machicado G; Smith J; Silpa M
    N Engl J Med; 1994 Feb; 330(6):382-6. PubMed ID: 8284002
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High doses of ranitidine in maintenance therapy of duodenal ulcer patients.
    Lee FI
    Scand J Gastroenterol Suppl; 1990; 178():67-71. PubMed ID: 2277970
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ranitidine and cimetidine in prevention of duodenal ulcer relapse. A double-blind, randomised, multicentre, comparative trial.
    Gough KR; Korman MG; Bardhan KD; Lee FI; Crowe JP; Reed PI; Smith RN
    Lancet; 1984 Sep; 2(8404):659-62. PubMed ID: 6147693
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical comparison of H2-antagonists.
    Smith K; Crisp C
    Conn Med; 1986 Dec; 50(12):815-7. PubMed ID: 3816221
    [No Abstract]   [Full Text] [Related]  

  • 45. Single nocturnal dose of an H2 receptor antagonist for the treatment of duodenal ulcer.
    Gledhill T; Howard OM; Buck M; Paul A; Hunt RH
    Gut; 1983 Oct; 24(10):904-8. PubMed ID: 6311692
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Duodenal ulcer. Who should have long-term maintenance therapy?
    Zuckerman G
    Postgrad Med; 1987 Oct; 82(5):52-3, 57-8, 60. PubMed ID: 2890147
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safety of ranitidine maintenance treatment of duodenal ulcer.
    Boyd EJ; Wilson JA; Wormsley KG
    Scand J Gastroenterol; 1984 May; 19(3):394-400. PubMed ID: 6330871
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Combined therapy using ranitidine and sucralfate in duodenal ulcer resistant to cimetidine].
    Uribarrena R; Arín A; Valera JI; Oreja M; Burusco MJ; Pueyo A; Fortún MT
    Rev Clin Esp; 1990 Apr; 186(7):328-31. PubMed ID: 2392595
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Maintenance treatment with cimetidine in peptic ulcer disease for up to 4 years.
    Walan A; Bianchi-Porro G; Hentschel E; Bardhan KD; Delattre M
    Scand J Gastroenterol; 1987 May; 22(4):397-405. PubMed ID: 3299677
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of changing the type of H2-blocker in the treatment of H2-blocker-resistant ulcers: comparison of roxatidine acetate hydrochloride and other H2-blockers.
    Yasutake K; Amano M; Mizokami Y; Kubota S; Fukumoto H; Imamura Y; Yokoya H; Irie K
    J Int Med Res; 1998; 26(1):25-36. PubMed ID: 9513074
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Therapy for ulcers and erosions associated with nonsteroidal anti-inflammatory drugs.
    Freeman HJ
    Can J Gastroenterol; 1998; 12(8):537-9. PubMed ID: 10206732
    [No Abstract]   [Full Text] [Related]  

  • 52. Prevention of relapse with various antiulcer drugs.
    Bresci G; Capria A; Federici G; Rindi G; Geloni M; Corsini G
    Scand J Gastroenterol Suppl; 1986; 121():58-62. PubMed ID: 3532297
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Asymptomatic duodenal ulcers occurring during maintenance treatment with ranitidine.
    Penston JG; Wormsley KG
    Aliment Pharmacol Ther; 1990 Dec; 4(6):569-76. PubMed ID: 2129644
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative efficacy of cimetidine & ranitidine.
    Talwalkar PG
    J Assoc Physicians India; 1987 Sep; 35(9):670. PubMed ID: 3436946
    [No Abstract]   [Full Text] [Related]  

  • 55. Cost-effectiveness of cimetidine maintenance therapy in chronic gastric and duodenal ulcer.
    Pym B; Sandstad J; Seville P; Byth K; Middleton WR; Talley NJ; Piper DW
    Gastroenterology; 1990 Jul; 99(1):27-35. PubMed ID: 2111784
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine.
    Ehsanullah RS; Page MC; Tildesley G; Wood JR
    BMJ; 1988 Oct; 297(6655):1017-21. PubMed ID: 3142593
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Ranitidine and cimetidine in long-term (2 years) maintenance therapy of chronic gastric ulcer].
    Varas MJ
    Rev Esp Enferm Apar Dig; 1989 Feb; 75(2):153-6. PubMed ID: 2652217
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double-blind, multicenter study.
    Raskin JB; White RH; Jaszewski R; Korsten MA; Schubert TT; Fort JG
    Am J Gastroenterol; 1996 Feb; 91(2):223-7. PubMed ID: 8607484
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Maintenance ranitidine treatment after haemorrhage from a duodenal ulcer. A 3-year study.
    Murray WR; Cooper G; Laferla G; Rogers P; Archibald M
    Scand J Gastroenterol; 1988 Mar; 23(2):183-7. PubMed ID: 3283916
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Therapy with H2 receptor antagonists in childhood. Use of ranitidine in duodenal and gastric ulcer and reflux esophagitis].
    Bender SW
    Fortschr Med; 1992 Nov; 110(33):629-32. PubMed ID: 1478605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.